Care Management Program for Complex & Rare Conditions Launched by Accredo

April 14, 2023

Alnylam Reports Successful Results in Highly Anticipated Heart Drug Study

June 24, 2024

Samsung Biologics to Shell Out $280M to Acquire GSK’s U.S. Plant

January 3, 2026

Must Read

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

July 26, 2026

Tempus purchases a specialist in cancer genomics in a $1.5 billion deal: Personalis

July 26, 2026

How RNA Therapeutics Are Expanding Beyond Rare Diseases

July 26, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Sanofi Ends Amlitelimab Development in Atopic Dermatitis After Phase 3 Program Review

J&J’s Bispecific Combination Works Wonders on Myeloma Progression in Phase 3 Study

Due to poor phase 2 data, Agios declares goodbye to the sickle cell program

Novartis Lets Go of Phase 2 Radioligand Therapy Following Clinic Disappointment

Tempus purchases a specialist in cancer genomics in a $1.5 billion deal: Personalis

Samsung Biologics Plans $1.8 Billion Acquisition of PolyPeptide

BeOne Invests $300 Million to Add Small Molecule Manufacturing at New Jersey Campus

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

How RNA Therapeutics Are Expanding Beyond Rare Diseases

The Future of AI-Assisted Clinical Operations

The End of Siloed Drug Development

Top 10 Reasons Commercial AI Requires Stronger Governance in Pharma

Tag: ANCA-Associated Vasculitis

Amgen Submits FDA Hearing Request to Defend Tavneos for ANCA-Associated Vasculitis

Editor Picks

Care Management Program for Complex & Rare Conditions Launched by Accredo

Alnylam Reports Successful Results in Highly Anticipated Heart Drug Study

Samsung Biologics to Shell Out $280M to Acquire GSK’s U.S. Plant

Must Read

Takeda’s Qdenga Makes History as First Vaccine to Get the Nod in India

Tempus purchases a specialist in cancer genomics in a $1.5 billion deal: Personalis

How RNA Therapeutics Are Expanding Beyond Rare Diseases

Hot Topics

About Us

Follow Us